Home/Blog
All Articles
November 25, 2019

Shoppable Services: Price Transparency Era’s First Real Business Bellwether

Many pharma executive and marketing leaders actively monitor the pricing transparency conversation in search of the meaningful insights that can truly impact their business performance. And while much public attention has been paid to items such as “drug costs in TV commercials” and “CEO testimony before Congress,” little evidence exists

November 19, 2019

How Predictive Modeling Can Demystify Spillover and Drive Market Access Advantage

In the world of pharma, spillover refers to instances in which healthcare providers (HCPs) alter their prescribing behavior in response to -- sometimes inaccurate -- perceptions of restricted access, or perhaps in response to patient complaints about co-pay burden or drug pricing. Learn about what's needed to predict spillover and avoid the problems that come with it.

Load More Posts